These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 16293160

  • 1. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN, Wung SF, Merkle CJ.
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [Abstract] [Full Text] [Related]

  • 2. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 3. Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.
    Tinelli A, Malvasi A, Leo G, Vergara D, Pisanò M, Ciccarese M, Chiuri VE, Lorusso V.
    Cancer Metastasis Rev; 2010 Jun 15; 29(2):339-50. PubMed ID: 20405170
    [Abstract] [Full Text] [Related]

  • 4. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M, Solomon S.
    Plast Surg Nurs; 2007 Jun 15; 27(3):124-7. PubMed ID: 17901820
    [Abstract] [Full Text] [Related]

  • 5. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.
    J Am Acad Nurse Pract; 2008 Feb 15; 20(2):76-84. PubMed ID: 18271762
    [Abstract] [Full Text] [Related]

  • 6. Hereditary ovarian cancer--assessing risk and prevention strategies.
    Pavelka JC, Li AJ, Karlan BY.
    Obstet Gynecol Clin North Am; 2007 Dec 15; 34(4):651-65, vii-viii. PubMed ID: 18061862
    [Abstract] [Full Text] [Related]

  • 7. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
    Maehle L, Apold J, Paulsen T, Hagen B, Løvslett K, Fiane B, Van Ghelue M, Clark N, Møller P.
    Clin Cancer Res; 2008 Nov 15; 14(22):7569-73. PubMed ID: 19010876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM, Senter L, Leventhal H, Ozakinci G, Porter K.
    Patient Educ Couns; 2008 Jan 15; 70(1):135-42. PubMed ID: 17988821
    [Abstract] [Full Text] [Related]

  • 11. Fibromyalgia--management of a misunderstood disorder.
    Peterson EL.
    J Am Acad Nurse Pract; 2007 Jul 15; 19(7):341-8. PubMed ID: 17680899
    [Abstract] [Full Text] [Related]

  • 12. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
    Friedenson B.
    MedGenMed; 2001 Nov 02; 3(6):2. PubMed ID: 11965197
    [Abstract] [Full Text] [Related]

  • 13. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP, Vadaparampil ST, Bower B, Friedman S, Keefe DL.
    Minerva Med; 2009 Oct 02; 100(5):371-83. PubMed ID: 19910890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Familial ovarian cancer.
    Elit L.
    Can Fam Physician; 2001 Apr 02; 47():778-84. PubMed ID: 11340759
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.